William Joseph Brennan

CEO William Joseph Brennan sold 54,984 shares in 28 transactions on 2026-06-05 for $12,017,876.60 at blended avg $218.57

William Joseph Brennan, President & Chief Executive Officer, executed 28 separate sales totaling 54,984 shares (55.0K shares) for $12,017,876.60 on 2026-06-05, representing a 13.0% reduction in his holdings from 422,311 shares to 367,327 shares. The multi-tranche execution across a range of prices ($206.40 to $230.36) occurred during a period of significant stock appreciation: the 30-day change is +24.3% and the 90-day change is +102.2%. At CRDO specifically, Brennan's prior four measurable sales have shown strong 90-day returns (ranging +86.7% to +119.1%), with a 0.00% well-timed rate at the 90-day mark—all prior sells at this ticker were followed by further stock rises. The current price of $234.32 is -4.7% from the 52-week high of $245.95, suggesting the stock remains near elevated levels following the extraordinary appreciation period.

CEO Brennan sells 12.3K shares at $101.45 in 2 tranches (total $1.2M); stock down 45.8% from 52-week high, 22.9% in 90 days.

Brennan William Joseph, as President & Chief Executive Officer, filed two separate sales totaling 12,298 shares for $1,247,632.10 at $101.45 per share on April 2 and April 5, 2026. The sales reduced his holdings by 5.2% to 222,311 shares. The timing is notable: the stock is trading at $102.46, down 45.8% from its 52-week high of $189.19 and down 22.9% over the past 90 days, despite the company posting strong fundamentals with revenue of $407.0M (growing +126.3% annually), net income of $157.1M, and a market cap of $18.9B. His cross-ticker track record shows 20 prior open-market sells with an average 30-day return of -14.4%, suggesting a pattern of sell decisions that have preceded further declines. The significance is elevated by the CEO role and the magnitude, but tempered by the shallow post-transaction holdings reduction and the absence of a timed positive signal within the latest transaction window.

CEO Brennan sold 68,016 shares (68.0K) for $8,003,801.83 ($8.0M) across 16 transactions on 2026-03-11

Brennan William Joseph, President & Chief Executive Officer, executed 16 separate sales totaling 68,016 shares for $8,003,801.83 on 2026-03-11 at a blended average price of $117.68, reducing his holdings from 1,850,518 to 1,782,502 shares. The sale occurs as the stock is down 37.8% from its 52-week high of $189.19 and down 8.3% over the prior 30 days. His prior five trades at CRDO (all in January 2026) showed negative returns ranging from -11.5% to -16.1% over 30 days, and his cross-ticker track record shows 20 prior sells with an average 30-day return of -12.6%. The company reports strong fundamentals with revenue of $407,012,000.00, net income of $157,142,000.00, and annual revenue growth of 126.3%, though the stock trades at a P/E of 63.96. The timing and magnitude of this divestiture warrant attention given the recent price weakness and the insider's recent pattern of sales.

CEO Brennan sold 68,016 shares ($8.7M) on 2026-01-29; stock now -36.6% from 52-week high, -16.2% over 30 days

Brennan William Joseph, CEO of CRDO, executed 24 separate sales on 2026-01-29 totaling 68,016 shares for $8,684,909.24, with a blended average price of $127.69. The current stock price of $119.96 stands 36.6% below the 52-week high of $189.19 and has declined 16.2% in the past 30 days and 27.0% over 90 days. This transaction occurred against a backdrop of sharp recent price deterioration after what the fundamentals showed as a period of strong growth: annual revenue growth of 126.3%, net income of $82.6M on revenue of $268.0M, and a market cap of $21.7B. The multi-tranche execution at prices ranging from $123.76 to $134.57 falls within a compressed band relative to recent 52-week range extremes, and the CEO retained 1,832,502 shares post-transaction, maintaining a substantial position. The timing and scale of the sale warrant attention given the sharp stock depreciation since execution and the company's elevated P/E ratio of 102.53 relative to recent profitability."

CEO Brennan sold 19,932 shares over 2 days for $2.7M (blended avg $137.18), reducing stake 6.9% to 270.6K shares remaining.

Brennan William Joseph, Pres & Chief Executive Officer, executed 26 separate sales totaling 19,932 shares for $2,734,233.81 across January 7–8, 2026, at prices ranging from $125.69 to $142.44. The blended average price of $137.18 sits below the current price of $150.42, indicating the CEO sold during a relative dip; the stock is currently down 4.8% over 30 days and down 20.5% from its 52-week high of $189.19. His post-transaction holdings remain substantial at 270.6K shares (6.9% reduction from prior 290.6K). The company shows strong fundamentals with quarterly revenue of $268.0M, net income of $82.6M, and annual revenue growth of +126.3%, yet carries a high P/E of 128.56. Prior sales at CRDO on 2025-12-11 occurred just weeks earlier, establishing a pattern of recent liquidation. Without disclosure flags indicating a scheduled plan, the timing and scale of these two-day sales warrant attention relative to recent stock weakness and the elevated valuation.

CEO William Joseph Brennan sells 68,016 shares for $10.4M at blended average $153.16, stock now trading 24.9% below 52-week high

Brennan William Joseph (Pres & Chief Executive Officer) executed 22 separate sales on 2025-12-11, totaling 68,016 shares for $10,417,523.14 at prices ranging from $149.36 to $159.20. The transaction reduced his holdings from 369,907 shares to 301,891 shares (-18.4%). The current price of $142.02 sits -24.9% from the 52-week high of $189.19, and the sale prices ($153.16 blended average) exceeded the current market level by approximately 11 points. At the same ticker (CRDO), his 5 prior sales in October showed mixed near-term outcomes ranging from -0.4% to +6.8% over 30 days, with no measurable 90-day horizon yet. The fundamentals show strong absolute performance—$268.0M quarterly revenue with 126.3% annual growth and $82.6M net income—but the P/E of 121.38 reflects a valuation premium that has compressed significantly from recent peaks.

CEO Brennan William Joseph sold 68,016 shares for $11.6M across 28 transactions on 2025-10-30, retaining 1.94M shares (3.4% reduction).

Brennan William Joseph, President & Chief Executive Officer of Credo Technology Group, executed 28 separate sales totaling 68,016 shares for $11,646,398.27 on 2025-10-30, at a blended average price of $171.23. This sale reduces his post-transaction holdings to 1,942,502 shares. The transaction occurs as CRDO trades near its 52-week high ($180.64 current price against a range of $33.30–$187.62), with the stock up 25.6% over 30 days and 63.8% over 90 days. The CEO's five prior transactions at CRDO (all on 2025-10-08) have outcome tracking not yet measurable, and his broader cross-ticker track record shows 20 prior sells, though the timing quality of those sales cannot yet be compared to this specific filing's execution. With the company posting annual revenue growth of +126.3% and a market cap of $31.2B, the scale of this divestiture and the filing's multi-transaction structure merit investor attention to assess whether the sales signal portfolio rebalancing or reflect management's perspective on valuation at current levels.

CEO Brennan sells 18,952 CRDO shares ($2.7M) across 23 transactions on 2025-10-07 to 2025-10-08 at blended $141.59; stock at $151.15

Brennan William Joseph, President and CEO of Credo Technology Group, executed 23 separate sales totaling 18,952 shares for $2,683,417.94 across two trading days (2025-10-07 through 2025-10-08), reducing his holdings by 5.3% from 356,875 to 337,923 shares. The blended average sale price of $141.59 is below the current price of $151.15, suggesting the sales occurred while the stock was trading below its present level. The multi-transaction structure—with prices ranging from $135.45 to $148.92—may indicate algorithmic execution or a prearranged trading schedule rather than discretionary opportunistic selling. Against a broader context of strong fundamentals (revenue of $223,074,000, net income of $63,399,000, and annual revenue growth of 126.3%), this concentrated divestiture warrants investor scrutiny regarding the timing, underlying rationale, and any constraints on the CEO's confidence in near-term performance.

CEO Brennan William Joseph sells 68,016 shares (68.0K) for $11,162,125.85 ($11.2M) across 16 transactions

Brennan William Joseph, President & Chief Executive Officer of Credo Technology Group Holding Ltd, executed 16 separate sales on 2025-09-16, selling a combined 68,016 shares (68.0K shares) for $11,162,125.85 ($11.2M) at a blended average price of $164.11. This sale reduces his holdings from 437,189 shares (437.2K shares) to 369,173 shares (369.2K shares), representing a -15.6% reduction. The current stock price of $172.31 is at the 52-week high (+0.0%), having gained +62.1% over 30 days and +101.5% over 90 days. The CEO's cross-ticker track record shows 20 prior sells with an average 30-day return of +14.8%, while his five prior trades at CRDO (all on 2025-09-11) are too recent for measurable 30- or 90-day outcomes. The substantial sale size and timing merit observation, particularly given the stock's recent steep ascent and the CEO's historical pattern of selling.

CEO Brennan William Joseph sold 9,476 shares (~$1.53M) across 8 transactions at $159.34–$166.26 on 2025-09-11.

CEO Brennan William Joseph executed 8 separate sales totaling 9,476 shares for $1,528,131.82 on 2025-09-11, reducing his holdings by 0.5% to 2,042,502 shares while the stock trades at $163.98, at the 52-week high. The blended average sale price of $161.26 sits $2.72 below the current price. Over his cross-ticker track record, this insider's 20 prior sells averaged +8.1% returns over 30 days and +83.4% over 90 days with a 0.00% well-timed rate; his 5 prior sales at CRDO (all on 2025-08-01) posted 30-day returns of +11.8% to +16.6%, indicating the stock has continued higher after each prior sale. The company reports revenue of $223,074,000.00 (latest quarter), net income of $63,399,000.00, annual revenue growth of +126.3%, and a P/E of 227.75. While the sale is modest relative to total holdings and the stock remains at all-time highs with strong recent momentum (+40.5% in 30 days, +105.7% in 90 days), the repetition of sell activity—including the same date as all five prior CRDO trades—alongside valuation metrics warrants tracking whether this pattern signals a systematic approach to portfolio management at this elevated price level.